Related Experiment Videos
Treatment approaches for metastatic cancer of the prostate based on recent molecular evidence
M N Middleman1, R M Lush, O Sartor
1Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Cancer Treatment Reviews
|March 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Integrated assessment of the effects of PFOA exposure on hepatic transcriptome and lipid profiles in mice expressing human PPARα.
Toxicology and applied pharmacology·2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Next generation radiotheranostics promoting precision medicine.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.
Cancer treatment reviews·2026
From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.
Cancer treatment reviews·2026
MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.
Cancer treatment reviews·2026